ANALYST INTERVIEW: BIOTECHNOLOGY INVESTMENT ISSUES: DENNIS PURCELL - PERSEUS-SOROS BIOPHARMACEUTICAL FUND.(PAK PAK, n.pr See pyridoxal-alpha-ketoglutarate. 903) BIOTECHNOLOGY INVESTMENT ISSUES: DENNIS PURCELL - PERSEUS-SOROS BIOPHARMACEUTICAL FUND. Reviews the performance of the industry, and examines recent changes that have impacted companies in that sector. Topics discussed include competition, mergers and acquisitions, and the development of customer demand; and a number of companies are identified that are considered well positioned to succeed in the current market. Sector: Biotechnology. Published date 5/8/02. Tickers featured: BMY, IMCL IMCL International Making Cities Livable IMCL Inter Marine Container Lines IMCL International Management Consultants Ltd. IMCL Indraprastha Medical Corp Ltd (India) IMCL Imperial Majesty Cruise Line , NVS, PSBF PSBF Protection Switch Byte Failure PSBF Professional Speakers Benefit Fund . Complete text approximately 3000 words. Document # PAK903. ANALYST INTERVIEWS, The Wall Street Transcript, 67 Wall Street, NY 10005. Voice (212) 952 7433. Fax: (212) 668-9842. E-mail: transcript@twst.com. *** |
|
|||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion